130 related articles for article (PubMed ID: 17381622)
1. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
Padley DJ; Dietz AB; Gastineau DA
Transfusion; 2007 Apr; 47(4):636-43. PubMed ID: 17381622
[TBL] [Abstract][Full Text] [Related]
2. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
[TBL] [Abstract][Full Text] [Related]
3. Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
Patah PA; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall EJ
Bone Marrow Transplant; 2007 Aug; 40(4):365-8. PubMed ID: 17572714
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
[TBL] [Abstract][Full Text] [Related]
5. Microbial contamination of harvested bone marrow and peripheral blood.
Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK
Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761
[TBL] [Abstract][Full Text] [Related]
6. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
[TBL] [Abstract][Full Text] [Related]
7. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?
Kelly M; Roy DC; Labbe AC; Laverdiere M
Bone Marrow Transplant; 2006 Aug; 38(3):183-8. PubMed ID: 16785868
[TBL] [Abstract][Full Text] [Related]
8. Infusion technique of hematopoietic progenitor cells and related adverse events (CME).
Mulay SB; Greiner CW; Mohr A; Bryant SC; Lingineni RK; Padley D; Hogan WJ; Gastineau DA; Jacob EK
Transfusion; 2014 Aug; 54(8):1997-2003; quiz 1996. PubMed ID: 24697759
[TBL] [Abstract][Full Text] [Related]
9. Microbial contamination of hematopoietic progenitor cell products.
Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
[TBL] [Abstract][Full Text] [Related]
10. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
[TBL] [Abstract][Full Text] [Related]
11. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
Lowder JN; Whelton P
Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
[TBL] [Abstract][Full Text] [Related]
12. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
[TBL] [Abstract][Full Text] [Related]
13. The effect of hematopoietic progenitor cells' temperature on cardiac arrhythmias in patients given peripheral blood progenitor cells.
Donmez A; Zoghi M; Cagirgan S; Acarlar C; Tombuloglu M
Transfus Apher Sci; 2006 Jun; 34(3):245-51. PubMed ID: 16931400
[TBL] [Abstract][Full Text] [Related]
14. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
15. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
[TBL] [Abstract][Full Text] [Related]
16. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
[TBL] [Abstract][Full Text] [Related]
17. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation.
Martin-Henao GA; Torrico C; Azqueta C; Amill B; Querol S; Garcia J
Transfusion; 2005 Dec; 45(12):1917-24. PubMed ID: 16371044
[TBL] [Abstract][Full Text] [Related]
18. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
Ozdemir E; Akgedik K; Akdogan S; Kansu E
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
[TBL] [Abstract][Full Text] [Related]
19. The role and impact of the transfusion medicine consultation service in the management of patients in the hematopoietic transplant service: A retrospective analysis.
Narvios A; Rodriguez-Jackson L; Reddy V; Lichtiger B
Transfus Clin Biol; 2009 Sep; 16(4):383-7. PubMed ID: 19665413
[TBL] [Abstract][Full Text] [Related]
20. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
Hoyt R; Szer J; Grigg A
Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]